40 YEARS OF EXPERIENCE

Neuraxpharm, your CNS specialist

Finding solutions for disorders related to the central nervous system.

Scroll to explore

CNS: Our focus at Neuraxpharm

Addressing a wide variety of CNS disorders to bring treatments to patients in need

Innovation: Transforming CNS care

Providing innovative solutions with the goal of improving quality of life for CNS patients

Neuraxpharm Commitment

1 in 4 people in the world will be affected by mental or neurological disorders at some point in their lives. This equates to nearly every family having at least one afflicted person in the home.

As a leading European pharmaceutical company specialized in the treatment of central nervous system (CNS) disorders, Neuraxpharm is committed to addressing the unmet needs of patients with psychiatric and neurological conditions.

Our purpose is to offer a comprehensive and specialized range of CNS therapeutic solutions to improve the daily lives of patients across Europe and beyond.

For doctors, pharmacists, caretakers, patients and their families, we are your expert CNS specialist.

Focusing on the early detection, prevention and treatment of chronic, severe and standard CNS disorders

Alzheimer's

Anxiety

Chronic pain

Depression

Epilepsy

Multiple Sclerosis

Parkinson's

Psychosis / Schizophrenia

Innovation

Visit our section on Innovation to see how we are addressing the unmet needs of CNS patients

Go to Innovation

Neuraxpharm News

As experts in CNS disorders, we bring you the latest news, product launches and innovative initiatives we constantly undertake to always stay ahead of developments in the CNS area.

Neuraxpharm tar sig in i den digitala hälsomarknaden med en bärbar enhet för epilepsi

Den bärbara enheten är utvecklad av mjn-neuro och ger en tidig varning för epileptiska anfall. Lanseringen kommer efter att vi redovisat resultaten från de kliniska prövningarna i slutet av 2023. Neuraxpharm har ett avtal som ensam återförsäljare i Europa.

Neuraxpharm appoints Philipp Pohoralek as new Country Manager for Germany

Europe’s leading CNS specialty company strengthens its management team in Germany and reinforces its growth strategy.

Neuraxpharm appoints Dr. Maximilian von Wülfing as COO

Europe’s leading CNS specialty company underpins strategy by reinforcing commercial structure with new Chief Operating Officer role.

Neuraxpharm strengthens European presence in the Nordics

The new business unit Neuraxpharm Sweden is based in Stockholm and will be led by Magnus Wassén, General Manager Neuraxpharm Nordics.

’Life-changing Minutes’, an initiative to help understand epilepsy

On the occasion of International Epilepsy Day, Neuraxpharm promotes the digital initiative: “Life-changing Minutes”, with the aim of raising awareness about this condition and contributing to its destigmatisation.

Neuraxpharm selected for prestigious pilot program to supply medical cannabis in France

Neuraxpharm today announces that its affiliate Neuraxpharm France has been selected as one of winners for the participation in a pilot program for the medical use of cannabis issued by The National Agency for the Safety of Medicines and Health Products (ANSM), together with Panaxia Labs, Israel’s largest medical cannabis manufacturer.

Neuraxpharm Blog

Understand more about psychiatric and neurological disorders. Our team of health care professionals and expert journalists across Europe works to consistently bring you scientifically solid, trustable information to answer your concerns.

Mental health

Why mental health is important

Good mental health is an important part of life, just like good physical health. We are constantly given advice on how to take care of our bodies, but for too long, what we should do for our mental health, who we should turn to and how we should understand it has been overshadowed.

Stress